<DOC>
	<DOCNO>NCT00004731</DOCNO>
	<brief_summary>The purpose study compare effect vary dosage coenzyme Q10 ( CoQ10 ) versus placebo treatment Parkinson 's disease ( PD ) patient early , untreated PD .</brief_summary>
	<brief_title>Parkinson 's Disease Treatment With Coenzyme Q10</brief_title>
	<detailed_description>Four group 20 subjects/group subject randomly assign receive CoQ10 ( dose 300 , 600 1200 mg/day ) match placebo . A subject must early PD require treatment . A subject evaluate Screening Visit , Baseline Visit ( subject begin take study drug ) visit 1 , 4 , 8 , 12 , 16 month baseline visit . The subject follow she/he need treatment levodopa maximum 16 month . Because CoQ10 component mitochondrion ( part cell make energy ) , blood sample take baseline visit last visit study mitochondrial function .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>The subject must three cardinal feature PD : slowness movement , rest tremor rigidity . The sign PD must great one side . Disorders mimic PD . Other serious medical problem .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>coenzyme Q10</keyword>
</DOC>